Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Satellos Bioscience Inc. (MSLE) had Stock-Based Compensation of $0.73M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-9.77M |
|
-- |
|
-- |
|
$10.04M |
|
$-10.04M |
|
$0.31M |
|
$-9.73M |
|
$-9.73M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-10.04M |
|
$-10.04M |
|
18.43M |
|
18.43M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$75.22M |
|
$0.01M |
|
$0.01M |
|
$75.23M |
|
$4.56M |
|
-- |
|
-- |
|
$4.56M |
|
$70.66M |
|
$70.66M |
|
$70.66M |
|
20.83M |
|
| Cash Flow Statement Financials | |
$-9.59M |
|
$-33.34M |
|
$51.90M |
|
$9.80M |
|
$18.70M |
|
$8.89M |
|
|
Stock-Based Compensation |
$0.73M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.82% |
|
-13.82% |
|
-12.98% |
|
-13.82% |
|
$3.39 |
|
$-0.52 |
|
$-0.52 |
|